"The next question is what is the size of the USA market? Will it generate revenue of $1b or $3b or more ? If sale are $3b the EBITDA is potentially $2.5b"
To reach $3bill in the US, it would need to reach 100% of all sales in the US - and the US market would first need to grow another 50%.
Total sales globally are around $4bill. US sales are $2bill.
We all like the big potential but asking if it could reach 150% market share is getting a bit carried away!
"By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Erectile Dysfunction Drugs market accounted for USD 1.92 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period."
https://www.marketresearchfuture.com/reports/erectile-dysfunction-drugs-market-1313#:~:text=By%20Region%2C%20the%20study%20provides,growth%20during%20the%20study%20period.
FDA Approval closer with Aptar in our corner, page-7
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.91 |
Change
0.025(1.33%) |
Mkt cap ! $160.6M | |||
| Open | High | Low | Value | Volume |
| $1.86 | $1.93 | $1.77 | $1.283M | 687.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 254 | $2.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 2500 | 1 |
View Market Depth
| Last trade - 15.59pm 04/10/2024 (20 minute delay) ? |
| LTP (ASX) Chart |